792 Results

People

  1. Kemeny
    Kemeny
  2. Kris
    Kris
  3. De Angelis
    De Angelis
  4. Giralt
    Giralt
  5. Usmani
    Usmani
  6. Landau
    Landau
  7. Hassoun
    Hassoun
  8. Yahalom
    Yahalom
  9. Comenzo
    Comenzo
  10. Posner
    Posner

Groups

  1. Department of Medicine (421)
  2. Hematologic Malignancies, Division of (207)
  3. Solid Tumor Oncology Division (206)
  4. Center for Hematologic Malignancies (205)
  5. Survivorship Research (119)
  6. Gastrointestinal Oncology Service (92)
  7. Center for Pancreatic Cancer Research (65)
  8. Surgery (65)
  9. Bone Marrow Transplant (61)
  10. Sloan Kettering Institute Faculty (60)
  1. "dexamethasone"
Formats
  1. Journal Article (719)
  2. Review (25)
  3. Conference Paper (14)
  4. Research Letter (13)
  5. Meeting Abstract (6)
  6. Correspondence (5)
  7. Editorial (5)
  8. Guidelines (4)
  9. Book Section (1)
Groups
  1. Department of Medicine (421)
  2. Hematologic Malignancies, Division of (207)
  3. Solid Tumor Oncology Division (206)
  4. Center for Hematologic Malignancies (205)
  5. Survivorship Research (119)
  6. Gastrointestinal Oncology Service (92)

More Groups

People
  1. Nancy Kemeny (66)
  2. Mark Kris (43)
  3. Lisa De Angelis (33)
  4. Saad Usmani (32)
  5. Sergio Giralt (32)
  6. Heather Landau (27)

More People

Years
  1. 2025 (23)
  2. 2024 (48)
  3. 2023 (34)
  4. 2022 (23)
  5. 2021 (9)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (56)
  2. Journal of the National Comprehensive Cancer Network (31)
  3. Cancer (27)
  4. Blood (23)
  5. Seminars in Oncology (21)
  6. British Journal of Haematology (18)

More Publications

Publishers
  1. Elsevier Inc. (130)
  2. American Society of Clinical Oncology (59)
  3. Lippincott Williams & Wilkins (48)
  4. Springer (44)
  5. Wiley Blackwell (44)
  6. Nature Publishing Group (43)

More Publishers

Results (792)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The cost-effectiveness of axicabtagene ciloleucel as second-line therapy in patients with large B-cell lymphoma in the United States: An economic evaluation of the ZUMA-7 trial
    Journal Article

    Perales, M. A.; Kuruvilla, J.; Snider, J. T.; Vadgama, S.; Blissett, R.; El-Moustaid, F.; Smith, N. J.; Patel, A. R.; Johnston, P. B.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: A systematic review and meta-analysis
    Review

    Patel, P.; Robinson, P. D.; Wahib, N.; Cheung, P.; Wong, T.; Cabral, S.; Parker, A.; Cohen, M.; Devine, K.; Gibson, P.; more...
    Supportive Care in Cancer (2022)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Correspondence

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Burge, M.; Korde, N.; Hassoun, H.; Lesokhin, A.; Lahoud, O.; Smith, E.; Hultcrantz, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Are we ready to look beyond plasma cells in assessing high-risk smoldering myeloma?
    Editorial

    Maclachlan, K. H.; Lesokhin, A. M.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Patterns of use, outcomes, and resource utilization among recipients of commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B cell lymphomas
    Journal Article

    Riedell, P. A.; Hwang, W. T.; Nastoupil, L. J.; Pennisi, M.; McGuirk, J. P.; Maziarz, R. T.; Bachanova, V.; Oluwole, O. O.; Brower, J.; Flores, O. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Research Letter

    Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: A case for response-adapted approach
    Journal Article

    Lahoud, O. B.; Landau, H.; Nguyen, J.; Devlin, S.; Lendvai, N.; Weltz, J.; Ayorinde, T.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Perspectives on the risk-stratified treatment of multiple myeloma
    Editorial

    Davies, F. E.; Pawlyn, C.; Usmani, S. Z.; San-Miguel, J. F.; Einsele, H.; Boyle, E. M.; Corre, J.; Auclair, D.; Cho, H. J.; Lonial, S.; more...
    Blood Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Triplet therapy, transplantation, and maintenance until progression in myeloma
    Journal Article

    Richardson, P. G.; Jacobus, S. J.; Weller, E. A.; Hassoun, H.; Lonial, S.; Raje, N. S.; Medvedova, E.; McCarthy, P. L.; Libby, E. N.; Voorhees, P. M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
    Review

    Kumar, S.; Baizer, L.; Callander, N. S.; Giralt, S. A.; Hillengass, J.; Freidlin, B.; Hoering, A.; Richardson, P. G.; Schwartz, E. I.; Reiman, A.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save